研究报告 |
|
|
|
|
HCV丝氨酸蛋白酶小分子底物构建及GST融合表达 |
胡巍1*,刘文1,凌世淦2 |
1.山东理工大学生命科学学院 淄博 255049
2.军事医学科学院基础医学研究所 北京 100850 |
|
Construction of a Small Peptide as a Surrogate of Natural Substrate of HCV Serine Protease and Fusion Expression with GST in Prokaryotic Cells |
1.School of Life Sciences, Shandong University of Technology, Zibo 255049, China
2.Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing 100850,China |
[1] Hoofnagle J H. Course and outcome of hepatitis C. Hepatology,2002,36(5):S21S29.
[2] Urbani A, Bianchi E, Narjes F, et al. Substrate specificity of the hepatitis C virus serine protease NS3. J Biol Chem, 1997,272(6): 92049209.
[3] Bartenschlager R. The NS3/ 4A proteinase of the hepatitis C virus:unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy. J Viral Hepat, 1999, 6 (3): 165181.
[4] 胡巍,凌世淦,宋晓国,等. 丙型肝炎病毒NS3蛋白酶在酵母表达系统中的可溶性表达. 中国生物化学和分子生物学学报, 2005,21(2):209214. Hu W,Ling S G,Song X G,et al.Chin J Biochem Mol Biol,2005,21(2): 209214.
[5] 凌世淦,宋晓国,胡巍,等.SARS病毒多表位抗原免疫原性研究. 解放军医学杂志,2003,28 (SARS专刊 ):68. Ling S G,Song X G,Hu W,et al.Med J PLA,2003,28(SARS supplement):68.
[6] Steinkuhler C, Koch U, Narjes F, et al. Hepatitis C virus protease inhibitors: current progress and future challenges. Curr Med Chem, 2001, 8(8):919932.
[7] Di Marco S, Rizzi M, Volpari C, et al. Inhibitor of the Hepatitis C virus NS3/NS4A protease. J Biol Chem, 2000,275(10):71527157.
[8] Sudo K, Matsumoto Y, Matsushima M, et al. Novel hepatitis C virus protease inhibitors: thiazolidine derivatives. Biochem Biophys Res Commun, 1997, 238(2):643647
[9] Rognvaldsson T, Etchells T A, You L W, et al. How to find simple and accurate rules for viral protease cleavage specificities.BMC Bioinformatics,2009,10(149):117.
[10] 胡巍,刘文,宋晓国,等. HCV NS5AB片段的表达及在酶活性研究中的应用. 细胞与分子免疫学杂志, 2006,22(1): 4346. Hu W,Liu W,Song X G,et al.Chin J Cell Mol Immunol,2006,22(1): 4346.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|